US pharma reviews get new lead staffer Daniel Zach in acting FTC role
The division reviewing pharmaceutical mergers at the US Federal Trade Commission has a new acting leader — Daniel Zach, the former deputy assistant director — according to a web update.The division...To view the full article, register now.
Already a subscriber? Click here to view full article